Jinghua Pharmaceutical Group Company Description

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China.

Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs.

The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and is based in Nantong, China.

Jinghua Pharmaceutical Group Co., Ltd.

Country	China
Founded	1957
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1,493
CEO	Yunzhong Zhou

Contact Details

Address: No 20, 3 Haibin Road Nantong, Jiangsu Province 226407 China
Phone	86 513 8560 9405
Website	jinghuapharm.com

Stock Details

Ticker Symbol	002349
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100000L14
SIC Code	2834

Key Executives

Name	Position
Yunzhong Zhou	GM and Vice Chairman
Yuxiang Wu	Executive Vice President, Chief Financial Officer and Director
Jianfeng Wang	Board Secretary